Use of polyclonal anti-hiv goat serum as a therapeutic agent

Details Use of polyclonal anti-hiv goat serum as a therapeutic agent Use of polyclonal anti-hiv goat serum as a therapeutic agent

A - Human Necessities

61

K

A61K 39/395 (2006.01) A61P 25/02 (2006.01) A61P 31/18 (2006.01) C07K 16/10 (2006.01) C07K 16/24 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2452986

Anti-HLA and other antibodies are present in goat serum after injection of HIV antigenic material, and form the basis for a most surprisingly effective treatment of HIV, multiple sclerosis and other conditions.

Des anti-HLA et d'autres anticorps sont présents dans un sérum de chèvre après injection d'un matériau antigène VIH, et constituent étonnamment la base du traitement le plus efficace du VIH, de différents types de scléroses et d'autres états.

Affiliated with

Also associated with

Rating

Use of polyclonal anti-hiv goat serum as a therapeutic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of polyclonal anti-hiv goat serum as a therapeutic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of polyclonal anti-hiv goat serum as a therapeutic agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1510144